Article
Could the CCR5-Delta32 mutation be protective in SARS-CoV-2 infection?
Physiological research - 16 Dec 2021
Starcevic Cizmarevic N, Kapovic M, Roncevic D, Ristic S
Abstract excerpt
Increasing evidence points to host genetics as a factor in COVID-19 prevalence and outcome. CCR5 is a receptor for proinflammatory chemokines that are involved in host responses, especially to viruses. The CCR5-delta32 minor allele is an interesting variant, given the role of CCR5 in some viral infections, particularly HIV-1. Recent studies of the impact of CCR5-delta32 on COVID-19 risk and severity have yielded...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
